Philip Charles Hoffman to Methylenetetrahydrofolate Reductase (NADPH2)
This is a "connection" page, showing publications Philip Charles Hoffman has written about Methylenetetrahydrofolate Reductase (NADPH2).
Connection Strength
0.047
-
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015. Breast Cancer Res Treat. 2020 Jun; 181(3):623-633.
Score: 0.047
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.